Clinical trial
Melatonin and Radiation Therapy in Treating Patients With Brain Metastases
NCT00031967 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00031967 |
|---|---|
| Title | Melatonin and Radiation Therapy in Treating Patients With Brain Metastases |
| Official title | A Randomized Phase II Study of A.M. and P.M. Melatonin for Brain Metastasis in RPA Class II Patients |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Cancer, Radiation Toxicity, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Radiation |
| Interventions | therapeutic melatonin, radiation therapy |
| Start date | May 1, 2002 |
| Primary completion | Mar 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Oct 22, 2020 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: